Sentence examples for ongoing turnover from inspiring English sources

Hambleton (1993) has noted that the toxin also enhances the ongoing turnover of NMJs, thus initiating physical recovery before full functional recovery.

This result indicates that there is ongoing turnover of basic metabolites necessary to support the fast pace of growth and development in immature anthers and that there is unexpectedly dynamic gene regulation of these core biochemical pathways.

Following this reasoning, one may speculate that the ease of reactivation of XP alleles in undifferentiated TS cells may be permitted by similar ongoing turnover of epigenetic marks such as H3K27me3.

Notwithstanding this possibility, there has clearly been ongoing turnover of the PSG gene family in all of the lineages analysed, as there are no known human orthologues of rat and mouse PSGs, and only four potential orthologous relationships between known rat and mouse PSGs.

Thus, apparent short-term variation in the rate of tRNA gene gain and loss may overall be better explained by repeat-driven expansion of pseudo-tRNAs and genome assembly artifacts rather than real deviation from the long-term process of steady-state tRNA gene number with ongoing turnover.

This brings the specificity constant for the PPIP5Ks much closer to that of the DIPPs (diphosphoinositol-polyphosphate phosphohydrolases) [ 44, 45], and as such is more consistent with the long-standing observation that there is high ongoing turnover of PP-Ins Ps in vivo [ 2, 28].

DMD muscles lack the dystrophin protein, and dystrophin gene replacement is expected to halt ongoing myofiber turnover.

It has been suggested to be involved in a variety of physiological processes, such as, ongoing synapse turnover [6], apoptosis [7], [8], cytoprotection at fluid-tissue boundaries, membrane recycling during development and in response to injury and regulation of complement-mediated membrane attack complex [9], [10].

Therefore, ongoing ECM turnover is necessary for homeostatic maintenance of the IOP.

Neither the autoimmune profile, the ongoing cartilage turnover nor local or systemic inflammation seems to influence the relapse rate.

Another approach which is increasingly being explored is based on the assumption that release of molecules/fragments from joint tissue into the circulation reflects ongoing tissue turnover.